MedPath

Development of a Scoring Model to Predict Completion of Chemoradiotherapy for Inoperable Stage III NSCLC

Not Applicable
Conditions
Inoperable Stage III Non-Small Cell Lung Cancer
Registration Number
JPRN-UMIN000054100
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
1288
Inclusion Criteria

Not provided

Exclusion Criteria

Exclude the following cases. (1) Cases in which completion of treatment was not noted.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath